Introduction of robot-assisted Robot-assisted sacrocolpopexy for pelvic organ prolapse

Introduction of robot-assisted Robot-assisted sacrocolpopexy for pelvic organ prolapse - Robot-assisted sacrocolpopexy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053845

Enrollment

Registered

2024-03-13

Start date

2024-03-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic organ prolapse

Interventions

Robot-assisted sacrocolpopexy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1) Patients with pelvic organ prolapse who wish to undergo surgical treatment using mesh fixation. (2) Patients who have received a full explanation of this treatment (surgery) and whose consent has been obtained (including consent for annual reporting to the Japanese Society of Obstetrics and Gynecology, which is mandatory for facilities that perform this treatment). (3) Patients with ECOG Performance Status 0-1 (4) Patients who can undergo general anesthesia (5) Patients who can undergo laparoscopic surgery

Exclusion criteria

Exclusion criteria: (1) Patients under 40 years of age and over 80 years of age 2) Patients with a possibility of uterine malignancy in the preoperative examination (3) Patients whose judgment ability seems to be inadequate (4) Patients for whom mesh fixation is considered difficult by internal examination and diagnostic imaging (5) Patients who are expected to have severe adhesions (6) Patients with severe obesity (7) Patients with a history of abdominal surgery that is considered difficult to perform laparoscopically (8) Patients with abdominal aortic aneurysm (9) Patients with cerebrovascular disorder (subarachnoid hemorrhage, cerebral infarction, transient ischemic attack, etc.) (10) Patients with severe glaucoma (11) Patients with poorly controlled diabetes mellitus (12) Women who are pregnant or may become pregnant (13) Other patients with serious complications that the surgeon determines to be difficult to treat in this study (this procedure).

Design outcomes

Primary

Measure	Time frame
To evaluate the safety and efficacy of robot-assisted Robot-assisted sacrocolpopexy for pelvic organ prolapse	—

Countries

Japan

Contacts

Public ContactYoko Nagayoshi

International University of Health and Welfare, Mita Hospital Gynecologic Oncology Center / Gynecology

y-nagayoshi@iuhw.ac.jp0334518121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026